Early single-center experience with middle meningeal artery embolization using Zoom

Access embolization intermediate catheter middle meningeal artery neurointervention

Journal

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences
ISSN: 2385-2011
Titre abrégé: Interv Neuroradiol
Pays: United States
ID NLM: 9602695

Informations de publication

Date de publication:
06 May 2024
Historique:
medline: 7 5 2024
pubmed: 7 5 2024
entrez: 7 5 2024
Statut: aheadofprint

Résumé

Middle meningeal artery (MMA) embolization for subdural hematomas (SDH) and dural arteriovenous fistulas (dAVFs) has gained momentum in the neuroendovascular space. However, there is variability in the technique for safe and effective embolization. The aim of this report is to describe the technical feasibility and clinical performance of using Zoom We analyzed all cases of MMA embolization in which the Zoom A total of 32 patients were included. Mean age was 64.0 ± 18.0 years, 75.0% (4/32) were male, and 56.7% (17/30), were black. The technical success was achieved in 93.8% (30/32) of cases, with selective embolization utilizing microcatheter directly into frontal and parietal branches for most patients (96.9%, 31/32). Identification of dangerous collaterals, such as lacrimal and petrous branches, prior to embolization, was achieved in most patients (96.9%, 31/32). Bilateral MMA embolization was done in 50.0% (16/32) of patients. The transradial approach and transfemoral approach were used in 53.1% (17/32) and 46.9% (15/32) of patients, respectively. The most common embolization material was n-butyl cyanoacrylate (84.4%, 27/32). There were no access site complications or complications related to the MMA embolization procedures and used devices. The use of Zoom

Sections du résumé

BACKGROUND BACKGROUND
Middle meningeal artery (MMA) embolization for subdural hematomas (SDH) and dural arteriovenous fistulas (dAVFs) has gained momentum in the neuroendovascular space. However, there is variability in the technique for safe and effective embolization. The aim of this report is to describe the technical feasibility and clinical performance of using Zoom
METHODS METHODS
We analyzed all cases of MMA embolization in which the Zoom
RESULTS RESULTS
A total of 32 patients were included. Mean age was 64.0 ± 18.0 years, 75.0% (4/32) were male, and 56.7% (17/30), were black. The technical success was achieved in 93.8% (30/32) of cases, with selective embolization utilizing microcatheter directly into frontal and parietal branches for most patients (96.9%, 31/32). Identification of dangerous collaterals, such as lacrimal and petrous branches, prior to embolization, was achieved in most patients (96.9%, 31/32). Bilateral MMA embolization was done in 50.0% (16/32) of patients. The transradial approach and transfemoral approach were used in 53.1% (17/32) and 46.9% (15/32) of patients, respectively. The most common embolization material was n-butyl cyanoacrylate (84.4%, 27/32). There were no access site complications or complications related to the MMA embolization procedures and used devices.
CONCLUSIONS CONCLUSIONS
The use of Zoom

Identifiants

pubmed: 38711176
doi: 10.1177/15910199241250078
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

15910199241250078

Déclaration de conflit d'intérêts

Declaration of conflicting interestsThe authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Rami Z Morsi (RZ)

Department of Neurology, University of Chicago, Chicago, IL, USA.

Sonam Thind (S)

Department of Neurology, University of Chicago, Chicago, IL, USA.

Archit Baskaran (A)

Department of Neurology, University of Chicago, Chicago, IL, USA.

Rohini Rana (R)

Department of Neurology, University of Chicago, Chicago, IL, USA.

Julián Carrión-Penagos (J)

Department of Neurology, University of Chicago, Chicago, IL, USA.

Harsh Desai (H)

Department of Neurology, University of Chicago, Chicago, IL, USA.

Sachin A Kothari (SA)

Department of Neurology, University of Chicago, Chicago, IL, USA.

Ahmad Chahine (A)

Department of Neurology, University of Chicago, Chicago, IL, USA.

Jehad Zakaria (J)

Department of Neurology, University of Chicago, Chicago, IL, USA.

Sean P Polster (SP)

Department of Neurosurgery, University of Chicago, Chicago, IL, USA.

James E Siegler (JE)

Department of Neurology, University of Chicago, Chicago, IL, USA.

Scott J Mendelson (SJ)

Department of Neurology, University of Chicago, Chicago, IL, USA.

Ali Mansour (A)

Department of Neurology, University of Chicago, Chicago, IL, USA.

Michael C Hurley (MC)

Department of Radiology, University of Chicago, Chicago, IL, USA.

Shyam Prabhakaran (S)

Department of Neurology, University of Chicago, Chicago, IL, USA.

Tareq Kass-Hout (T)

Department of Neurology, University of Chicago, Chicago, IL, USA.
Department of Neurosurgery, University of Chicago, Chicago, IL, USA.

Classifications MeSH